This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Clinical Commissioning Group Improvement and Assessment Framework | |
|---|---|
| Name | Clinical Commissioning Group Improvement and Assessment Framework |
| Jurisdiction | National Health Service England |
Clinical Commissioning Group Improvement and Assessment Framework The Clinical Commissioning Group Improvement and Assessment Framework is an English National Health Service assessment mechanism used to evaluate Clinical commissioning group performance against strategic, operational and financial criteria. It synthesises metrics drawn from statutory bodies such as NHS England, Care Quality Commission, NHS Digital and local partners including Healthwatch England and integrated care systems like NHS North East London. The framework has informed commissioning oversight during major policy moments such as the passage of the Health and Social Care Act 2012 and later system reorganisations under the NHS Long Term Plan.
The framework provided a structured approach for assessing the capacity of Clinical commissioning groups to commission services across pathways including primary care, acute care, mental health services, and community health services. It aligned NHS England assurance activities with financial regimes set by HM Treasury and operational expectations within the NHS Constitution for England. Assessments were communicated to local leaders, Chairs drawn often from institutions such as Royal College of General Practitioners and executive teams linked to organisations like NHS Improvement.
Designed to drive accountability after the implementation of the Health and Social Care Act 2012, the framework aimed to accelerate improvements in commissioning outcomes, workforce planning and patient safety culture. Development involved consultation with stakeholder bodies including British Medical Association, Royal College of Nursing, Local Government Association and patient advocacy organisations such as Citizens Advice. Iterations reflected policy shifts influenced by documents like the Five Year Forward View and the NHS Long Term Plan, and learning from inquiries such as the Francis Report.
Assessment domains typically encompassed performance areas mapped to commissioning responsibilities: quality of care, financial control, leadership and governance, strategic commissioning, and patient experience. Indicators referenced data from national datasets including Hospital Episode Statistics and measures aligned with programmes like Better Care Fund and Summary Care Record adoption. Quality dimensions related to standards set by the Care Quality Commission and workforce indicators referenced professional regulators such as the General Medical Council and the Nursing and Midwifery Council.
The framework drew on multiple data streams: statutory returns managed by NHS Digital, regulatory ratings from the Care Quality Commission, national performance statistics maintained by NHS England and local intelligence from Healthwatch England and local authorities. Methodology combined quantitative scoring against thresholds used by NHS Improvement with qualitative assurance via assurance panels including representatives from regional offices like NHS England North West. Peer review processes often reflected methods used in Clinical audit and governance reviews influenced by standards from bodies such as Audit Commission predecessors.
Outcomes under the framework produced categorical ratings used to indicate risk and requisite support: outstanding, good, requires improvement and inadequate—terminology resonant with Care Quality Commission classifications. Reports were shared with Boards of Clinical commissioning groups, regional directors at NHS England and, where relevant, Secretary of State for Health and Social Care briefings. Public summaries sometimes appeared alongside commissioning intentions and joint forward plans negotiated with local authorities and Integrated Care Partnerships.
By consolidating oversight, the framework affected commissioning behaviours, incentivising service redesigns that paralleled initiatives like vanguard sites and Integrated Care Systems. It influenced decisions on provider procurement, contracting strategies with trusts such as NHS Foundation Trusts and commissioning of services from independent sector providers including Care UK. Financial control measures within the assessment intersected with directives from Department of Health and Social Care and impacted CCG merger and devolution choices involving entities like Greater Manchester Combined Authority.
Critics argued the framework created administrative burdens reminiscent of debates surrounding the Health and Social Care Act 2012 reforms and risked short-termism comparable to concerns raised after Winterbourne View and the Francis Report. Concerns pointed to data lag, perverse incentives and overlap with inspections by the Care Quality Commission and functions of NHS Improvement. Subsequent reforms sought to streamline assurance within broader system oversight models promoted by the NHS Long Term Plan and enacted changes involving Integrated Care Systems and the abolition or redesign of Clinical commissioning group structures under later legislative and policy initiatives.